对SCN5A突变的临床,遗传和生物物理特征与心房导阻断相关
Dao W Wang1, Prakash C Viswanathan, Jeffrey R Balser
1Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn, and Department of Pediatrics, Medical University of South Carolina, Charleston, USA.
Circulation
|January 24, 2002
概括
在心房 (AV) 阻塞的儿童中,SCN5A基因 (G298S和D1595N) 发现了两种新型突变,导致通道功能受损和心肌导电减缓.
科学领域:
- 心血管遗传学 心血管遗传学
- 分子心脏病学分子心脏病学
- 离子通道生理学 离子通道生理学
背景情况:
- 在SCN5A基因的异构基因突变与心律失常障碍,如长QT综合征和布鲁加达综合征有关.
- SCN5A编码了心脏电压门的通道的α子单元,这对心脏的电活动至关重要.
研究的目的:
- 研究两种新发现的SCN5A突变的临床,遗传和生物物理特征.
- 为了确定这些突变对心脏通道功能的功能影响,以及它们与心房 (AV) 导电阻塞的关联.
主要方法:
- 在两个被诊断为AV阻塞的儿科患者中SCN5A基因测序.
- 在 tsA201 细胞中表达的重组突变通道 (G298S 和 D1595N) 的全细胞补丁记录.
- 动能模拟用于预测突变对心肌导电速度的影响.
主要成果:
- 确定了两个新的SCN5A突变:G298S在域I S5-S6循环中的G298S和D1595N在域IV S3段中的D1595N.
- 这两种突变都影响了快速无活化,并降低了电流密度,而不会导致持续的非无活化电流.
- 突变增强了较慢的失活元件,导致预测的心肌导电速度显著减缓.
结论:
- 鉴定出一种与SCN5A突变和AV阻塞相关的生物物理异常的独特模式.
- 这些发现提供了关于单个离子通道基因突变如何导致心律失常的不同临床表型的见解.
更多相关视频
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
10.2K
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
2.0K
相关概念视频
01:19Electrophysiology of Normal Cardiac Rhythm
7.8K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
7.8K
01:28Mechanism of Cardiac Arrhythmias
2.7K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
557
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
01:18Dysrhythmias IV: Characteristics of Bradyarrhythmias
788
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
788
01:25Cardiomyopathy I: Introduction and Classification
821
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
821
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
804
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
804